Print（PDF/154KB） Mar. 04, 2025 Corporate

Sumitomo Pharma Announces Changes in Executive Officers and Other Key Positions

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Toru Kimura) today announced the following changes in Executive Officers and other key positions, effective April 1, 2025.

I. Changes in Executive Officers

(1) Promotion (effective April 1, 2025)

Member, Board of Directors, Managing Executive Officer
Tsutomu Nakagawa (currently Member, Board of Directors, Executive Officer)

(2) Departing Executive Officer (effective March 31, 2025)

Atsuko Higuchi (currently Managing Executive Officer)

(3) Changes in the Positions Assumed by Executive Officers (effective April 1, 2025)

Position as of April 1, 2025	Current position	Name
Representative Director, Executive Vice President Global Corporate Strategy; Global Finance Administration External Affairs; Corporate Governance; IT Management & Data Analytics	Representative Director, Executive Vice President Global Corporate Strategy; Global Finance; Legal & Compliance; Intellectual Property; Human Resources; External Affairs; Corporate Governance; IT Management & Data Analytics Administration	Motoyuki Sakai
Executive Officer Legal & Compliance; Intellectual Property; Human Resources	Executive Officer Legal & Compliance; Intellectual Property; Human Resources	Kimihiro Mizuno

II. Changes in Personnel (effective April 1, 2025)

Corporate Departments

Position as of April 1, 2025	Current position	name
Vice President, Head of Global Finance Senior Director, Financial Planning & Analysis	Senior Director, Financial Planning & Analysis, Global Finance	Koichiro Inoue
Senior Legal Officer	Vice President, Sumitomo Pharma America, Inc.	Tetsuya Uyama